AxoGen (AXGN) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
AxoGen, Inc. (AXGN) PT Raised to $26 at Canaccord Genuity
February 25, 2025 4:39 PM ESTCanaccord Genuity analyst Kyle Rose raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $26.00 (from $22.00) while maintaining a Buy rating.
The analyst commented, "AXGN posted strong Q4 results, beating top- and bottom-line expectations while again generating cash flow. AXGN notes its positive performance reflects ongoing... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond James
February 25, 2025 4:00 PM ESTRaymond James analyst Jayson Bedford raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $23.00) while maintaining a Outperform rating.
The analyst comments "AXGNs initial 2025 guidance was well above our expectation and the investor day preview (highlighted by an expectation of... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink Partners
February 25, 2025 1:07 PM ESTLeerink Partners analyst Mike Kratky raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We are reiterating our Outperform rating on AXGN and increasing our PT to $25 (from $18) following the company's 4Q24 earnings. Consistent with its preannouncement (see HERE),... More



